Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non-histaminergic angioedema
Publication date
2022-12
Authors
Alizadeh Aghdam, Mehran
Hofman, Zonne L M
Meertens, Michelle A.J.
Lebens, Ans F M
Hack, Erik
Knulst, A C
Maas, Coen
Röckmann, Heike
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
cc_by_nc
Abstract
Keywords
Angioedema/drug therapy, Angioedemas, Hereditary, Bradykinin, Complement C1 Inactivator Proteins, Complement C1 Inhibitor Protein/therapeutic use, Esterases, Humans, Urticaria, Immunology and Allergy, Immunology, Letter
Citation
Alizadeh Aghdam, M, Hofman, Z L M, Meertens, M, Lebens, A, Hack, C E, Knulst, A C, Maas, C & Röckmann, H 2022, 'Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non-histaminergic angioedema', Allergy: European Journal of Allergy and Clinical Immunology, vol. 77, no. 12, pp. 3673-3676. https://doi.org/10.1111/all.15437